Nebula Research & Development’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,608
Closed -$1.76M 166
2025
Q2
$1.76M Buy
3,608
+1,887
+110% +$1.08M 0.15% 222
2025
Q1
$1.06M Sell
1,721
-2,117
-55% -$1.2M 0.1% 355
2024
Q4
$2.03M Buy
+3,838
New +$2.16M 0.24% 99
2024
Q3
Sell
-2,041
Closed -$1.11M 958
2024
Q2
$1.11M Buy
2,041
+1,469
+257% +$841K 0.18% 192
2024
Q1
$367K Buy
+572
New +$347K 0.08% 463
2023
Q3
Sell
-378
Closed -$205K 510
2023
Q2
$205K Buy
+378
New +$207K 0.16% 270

Other funds holding CHE

Nebula Research & Development's CHE Position: Q3 2025 in Review

Nebula Research & Development sold out of Chemed (CHE) in Q3 2025, closing a stake of 3,608 shares — an estimated $1.76M sold.

Nebula Research & Development first reported a position in CHE in Q2 2023 and held it in 6 quarters. The position peaked at $2.03M in Q4 2024. 522 funds tracked by Wall St. Rank hold CHE as of Q3 2025.

  • Nebula Research & Development reported no remaining Chemed position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 3,608 Chemed shares in Q3 2025, an estimated $1.76M.
  • Nebula Research & Development first reported a position in Chemed in Q2 2023 and held it in 6 quarters.
  • Nebula Research & Development's Chemed position peaked at $2.03M in Q4 2024.
  • 522 funds tracked by Wall St. Rank held Chemed as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.